.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Julphar
Federal Trade Commission
Teva
Cipla
Dow
Citi
Medtronic
Boehringer Ingelheim

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040253

« Back to Dashboard

NDA 040253 describes ETHOSUXIMIDE, which is a drug marketed by Akorn, Bionpharma Inc, Heritage Pharms Inc, Mikart, Pharm Assoc, and Teva Pharms, and is included in six NDAs. It is available from ten suppliers. Additional details are available on the ETHOSUXIMIDE profile page.

The generic ingredient in ETHOSUXIMIDE is ethosuximide. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.

Summary for 040253

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details

Pharmacology for NDA: 040253

Medical Subject Heading (MeSH) Categories for 040253

Suppliers and Packaging for NDA: 040253

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ETHOSUXIMIDE ethosuximide SYRUP;ORAL 040253 ANDA Pharmaceutical Associates, Inc. 0121-0670 0121-0670-16 473 mL in 1 BOTTLE (0121-0670-16)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength250MG/5ML
Approval Date:Nov 22, 2000TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Merck
Fuji
Harvard Business School
Baxter
Farmers Insurance
McKesson
Colorcon
Deloitte
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot